23 reports

  • Cedar Pollen Allergy - Drug Profiles
  • RGI-1001 - DRUG PROFILE

About ## percent of people who have food allergies are allergic to more than one food.

  • Chemotherapy
  • Monoclonal Antibody
  • Pharmaceutical
  • Japan
  • Product Initiative
  • Cedar Pollen Allergy - Drug Profiles

BIOLOGIC FOR CEDAR POLLEN ALLERGY - DRUG PROFILE OMALIZUMAB - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description omalizumab F.

  • Chemotherapy
  • Monoclonal Antibody
  • Pharmaceutical
  • Japan
  • Product Initiative
  • UB-221 - DRUG PROFILE

The drug candidates target the allergens (Derp ##) that can trigger allergies and asthma attacks directly.

  • Asthma
  • Chemotherapy
  • HIV AIDS
  • Monoclonal Antibody
  • AstraZeneca PLC

THE DRUG CANDIDATE ACTS BY TARGETING DIPEPTIDASE-##.

  • Blood Disease
  • Chemotherapy
  • HIV AIDS
  • Monoclonal Antibody
  • Bristol-Myers Squibb Company

THE DRUG CANDIDATE IS A ## MER PEPTIDE ACTS BY TARGETING PROGRAMMED CELL DEATH ## LIGAND ## (PD-L##).

  • Blood Disease
  • Chemotherapy
  • HIV AIDS
  • Monoclonal Antibody
  • Bristol-Myers Squibb Company
  • trials that will further assess treatment of subsequent asthma attacks in mepolizumab-naive as well as previously-treated patients.
  • MEPOLIZUMAB - DRUG PROFILE

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Chemotherapy
  • Monoclonal Antibody
  • Respiratory Disease
  • United States
  • Product Initiative
  • trials that will further assess treatment of subsequent asthma attacks in mepolizumab-naive as well as previously-treated patients.
  • MEPOLIZUMAB - DRUG PROFILE

The company offers drugs in the areas of nephrology, oncology, immunology and allergy, central nervous system among others.

  • Blood Disease
  • Chemotherapy
  • HIV AIDS
  • Monoclonal Antibody
  • United States
  • trials that will further assess treatment of subsequent asthma attacks in mepolizumab-naive as well as previously-treated patients.
  • MEPOLIZUMAB - DRUG PROFILE

The drug candidate is in Phase II stage for peanut allergy in adults and pediatrics, grass pollen allergy and dermatitis globally.

  • Chemotherapy
  • Digestive System Disorder
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • MEPOLIZUMAB - DRUG PROFILE

The drug candidate is in Phase II stage for peanut allergy, grass pollen allergy, chronic urticaria, and dermatitis globally.

  • Chemotherapy
  • Chronic Disease
  • HIV AIDS
  • Monoclonal Antibody
  • Regeneron Pharmaceuticals, Inc.
  • MEPOLIZUMAB - DRUG PROFILE

The molecules developed by Companies in Pre-Registration, Filing rejected/ Withdrawn, Phase III, Phase II, Phase I and Preclinical stages are ##, ##, ##, ##, ## and ## respectively.

  • Chemotherapy
  • HIV AIDS
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • MEPOLIZUMAB - DRUG PROFILE

About ## percent of people who have food allergies are allergic to more than one food.

  • Chemotherapy
  • Monoclonal Antibody
  • Therapy
  • Canada
  • United States
  • TRIALS THAT WILL FURTHER ASSESS TREATMENT OF SUBSEQUENT ASTHMA ATTACKS IN MEPOLIZUMAB-NAIVE AS WELL AS PREVIOUSLY-TREATED PATIENTS.
  • MEPOLIZUMAB - DRUG PROFILE

ABOUT ## PERCENT OF PEOPLE WHO HAVE FOOD ALLERGIES ARE ALLERGIC TO MORE THAN ONE FOOD.

  • Chemotherapy
  • HIV AIDS
  • Monoclonal Antibody
  • United States
  • Product Initiative

Drug/ Molecule refers to Primary Intervention only. ##.

  • Chemotherapy
  • Digestive System Disorder
  • HIV AIDS
  • Monoclonal Antibody
  • World
  • MEPOLIZUMAB - DRUG PROFILE

About ## percent of people who have food allergies are allergic to more than one food.

  • Chemotherapy
  • Chronic Disease
  • Monoclonal Antibody
  • United States
  • Regeneron Pharmaceuticals, Inc.
  • DEXAMETHASONE - DRUG PROFILE

The drug candidate targets P/ neurokinin ## (NK##) receptors.

  • Chemotherapy
  • HIV AIDS
  • United States
  • Product Initiative
  • Helsinn Group
  • DEXAMETHASONE - DRUG PROFILE
  • DEXAMETHASONE - DRUG PROFILE

The drug candidate targets P/ neurokinin ## (NK##) receptors.

  • Chemotherapy
  • HIV AIDS
  • United States
  • Product Initiative
  • Helsinn Group
  • MEPOLIZUMAB - DRUG PROFILE

About ## percent of people who have food allergies are allergic to more than one food.

  • Chemotherapy
  • Monoclonal Antibody
  • Pharmaceutical
  • Respiratory Disease
  • Regeneron Pharmaceuticals, Inc.
  • MEPOLIZUMAB - DRUG PROFILE

The company offers drugs in the areas of nephrology, oncology, immunology and allergy, central nervous system among others.

  • Chemotherapy
  • HIV AIDS
  • Monoclonal Antibody
  • Therapy
  • United States

The FACT ## trial is evaluating the safety and efficacy of Genentech s drugs, Herceptinand Perjeta, and chemotherapy, in early stage breast cancer patients selected with Celcuity s CELx HSF Test.

  • Chemotherapy
  • HIV AIDS
  • Infectious Disease
  • Monoclonal Antibody
  • Grifols, S.A.
  • MEPOLIZUMAB - DRUG PROFILE

This explains the need for a high drug dose of IXF-## as supported by the findings of the recently published post-hoc analysis.

  • Chemotherapy
  • HIV AIDS
  • Monoclonal Antibody
  • United States
  • Product Initiative

RESULTS WERE PUBLISHED IN THE INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY.

  • Chemotherapy
  • HIV AIDS
  • Monoclonal Antibody
  • Pharmaceutical
  • Opiant Pharmaceuticals, Inc.
  • IMMUNOLOGY DRUGS MARKET, GLOBAL, TABLE OF ALL CLINICAL STAGE PIPELINE PRODUCTS,

Food Allergy.

  • Chemotherapy
  • HIV AIDS
  • Monoclonal Antibody
  • Company Financials
  • Forecast
  • MEPOLIZUMAB - DRUG PROFILE

The company offers drugs in the areas of nephrology, oncology, immunology and allergy, central nervous system among others.

  • Chemotherapy
  • HIV AIDS
  • Monoclonal Antibody
  • Research And Development
  • AstraZeneca PLC